BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Treatment
124 results:

  • 1. Immune checkpoint inhibitors with chemotherapy for primary advanced mismatch repair-deficient endometrial cancer: A cost-effectiveness analysis.
    Kim J; Lim J; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim DY
    Gynecol Oncol; 2023 Dec; 179():106-114. PubMed ID: 37976756
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.
    Bai L; Chen Y; Han L; Zheng A; Mo X
    BMC Womens Health; 2023 May; 23(1):252. PubMed ID: 37165420
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study.
    Benbrook DM; Deng W; Gold MA; Rai R; Conrad R; van der Wel H; Husain S; Moore K; Spirtos N; Jackson AL; Zakhour M; Mathews CA; West CM
    Gynecol Oncol; 2023 Apr; 171():67-75. PubMed ID: 36827840
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Endometrial carcinosarcoma.
    Bogani G; Ray-Coquard I; Concin N; Ngoi NYL; Morice P; Caruso G; Enomoto T; Takehara K; Denys H; Lorusso D; Coleman R; Vaughan MM; Takano M; Provencher DM; Sagae S; Wimberger P; Póka R; Segev Y; Kim SI; Kim JW; Candido Dos Reis FJ; Ramirez PT; Mariani A; Leitao M; Makker V; Abu-Rustum NR; Vergote I; Zannoni G; Tan D; McCormack M; Paolini B; Bini M; Raspagliesi F; Benedetti Panici P; Di Donato V; Muzii L; Colombo N; Pignata S; Scambia G; Monk BJ
    Int J Gynecol Cancer; 2023 Feb; 33(2):147-174. PubMed ID: 36585027
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma.
    Di Dio C; Bogani G; Di Donato V; Cuccu I; Muzii L; Musacchio L; Scambia G; Lorusso D
    Gynecol Oncol; 2023 Feb; 169():27-33. PubMed ID: 36493574
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Advanced and recurrent endometrial cancer: State of the art and future perspectives.
    Tronconi F; Nero C; Giudice E; Salutari V; Musacchio L; Ricci C; Carbone MV; Ghizzoni V; Perri MT; Camarda F; Gentile M; Berardi R; Scambia G; Lorusso D
    Crit Rev Oncol Hematol; 2022 Dec; 180():103851. PubMed ID: 36257537
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
    Middelkoop MA; de Lange ME; Clark TJ; Mol BWJ; Bet PM; Huirne JAF; Hehenkamp WJK
    Hum Reprod; 2022 May; 37(5):884-894. PubMed ID: 35143669
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Management of symptomatic uterine fibroids after ulipristal acetate suspension and identification of high risk patients for surgery at 6-months of follow-up.
    Nicolás I; Martínez-Zamora MÁ; Gracia M; Carrion A; Feixas G; Bernal L; Quintas L; Rius M; Castelo-Branco C; Carmona F
    Gynecol Endocrinol; 2021 Sep; 37(9):831-835. PubMed ID: 34044726
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. An unusual presentation of choriocarcinoma co-existing with pregnancy, successful delivery, and treatment: A case report and literature review.
    Igbodike EP; Adepiti CA; Ajenifuja KO; Onwudiegwu UU; Adejuyigbe GB; Mogaji IK
    Niger J Clin Pract; 2021 Mar; 24(3):446-451. PubMed ID: 33723122
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Highlights on Medical treatment of uterine Fibroids.
    Angioni S; D'Alterio MN; Daniilidis A
    Curr Pharm Des; 2021; 27(36):3821-3832. PubMed ID: 33388011
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinico-pathological features associated with mismatch repair deficiency in endometrial undifferentiated/dedifferentiated carcinoma: A systematic review and meta-analysis.
    Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Riccardi C; Mollo A; Zullo F; Insabato L
    Gynecol Oncol; 2021 Feb; 160(2):579-585. PubMed ID: 33276986
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
    Ekanem E; Talaulikar V
    Adv Ther; 2021 Jan; 38(1):137-148. PubMed ID: 33201387
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epithelioid trophoblastic tumor that requires fertility preservation: A case report and review of literature.
    Qian XQ; Shen YM; Wan XY; Xie X
    Taiwan J Obstet Gynecol; 2020 Sep; 59(5):736-739. PubMed ID: 32917327
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Suspension of ulipristal acetate for uterine fibroids during ongoing ema's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!
    Rozenberg S; Revercez P; Fastrez M; Vandromme J; Bucella D
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():300-302. PubMed ID: 32650189
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. What does non-eligibility for myoma surgery mean in the context of sequential prescription of ulipristal acetate?
    Pourcelot AG; Capmas P; Laberge P; Fernandez H
    J Gynecol Obstet Hum Reprod; 2020 Apr; 49(4):101688. PubMed ID: 31972353
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
    Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
    Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
    Sato S; Yamamoto E; Niimi K; Ino K; Nishino K; Suzuki S; Kotani T; Kajiyama H; Kikkawa F
    Int J Clin Oncol; 2020 Jan; 25(1):203-209. PubMed ID: 31520175
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of extrauterine epithelioid trophoblastic tumors.
    Zhang T; Zeng X; Xu H; Gao L; Xiong L; An R; Xue Y
    Arch Gynecol Obstet; 2019 Sep; 300(3):725-735. PubMed ID: 31312959
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy.
    Gadducci A; Carinelli S; Guerrieri ME; Aletti GD
    Gynecol Oncol; 2019 Jun; 153(3):684-693. PubMed ID: 31047719
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Extragonadal Yolk Sac Tumor Limited to the Myometrium: Report of a Case With Potential Fertility Preservation and Molecular Analysis Suggesting Germ Cell Origin.
    Simpson S; Simoni M; Hui P; Taylor HS; Buza N
    Int J Gynecol Pathol; 2020 May; 39(3):247-253. PubMed ID: 31033797
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.